Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FKPYT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,517
Award facts
- Contract value 100% obligated
- $68,517.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $68,517.09 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 ml vials. This firm fixed price, non-set-aside contract was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this delivery order through its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs.
This delivery order represents a routine transaction within AmerisourceBergen's extensive federal contract portfolio with the DLA Medical Supply Chain, which encompasses a wide spectrum of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The contract demonstrates the contractor's capability to meet federal procurement requirements through competitive award processes and reflects the company's role as a key supplier for specialized pharmaceutical commodities across multiple therapeutic domains. The DLA's broader Pharmaceutical Prime Vendor Global Program Generation V initiative, which contemplates multiple regional awards among different contractors, provides the strategic framework within which this and similar delivery orders are executed.
Quick answers
Who was awarded contract SPE2DB25FKPYT?
SPE2DB25FKPYT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FKPYT worth?
The government has obligated $68,517 on SPE2DB25FKPYT.
Is contract SPE2DB25FKPYT an order under another contract?
Yes. SPE2DB25FKPYT is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKPYT competed?
The extent of competition for SPE2DB25FKPYT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award